Literature DB >> 3058606

Increase in vascular permeability of rat and guinea pig skin by T-kinin.

K Sugio1, L M Greenbaum.   

Abstract

The vascular permeability-increasing response to T-kinin in rat and guinea pig skin was investigated. The vascular permeability was measured with 125I-labeled bovine serum albumin [( 125I]BSA) as a tracer. Plasma exudation rapidly occurred 0-15 min after the intradermal injection of T-kinin. T-kinin in doses of 0.3, 1, and 3 nM/spot significantly increased the vascular permeability in a dose-dependent manner. The vascular response of T-kinin is similar to that of bradykinin. On the other hand, T-kinin analogs, D-Ile-Ser-bradykinin and Ile-D-Ser-bradykinin only weakly enhanced the vascular permeability. Prostaglandin E1, forskolin, and the angiotensin-converting enzyme inhibitor, SQ-14225, potentiated the T-kinin-induced plasma exudation. Cyproheptadine and indomethacin did not affect the T-kinin-induced response. The results suggest that T-kinin will play an important role in increasing vascular permeability associated with inflammation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3058606     DOI: 10.1007/bf00919434

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  12 in total

1.  Major acute phase alpha 1-protein of the rat is homologous to bovine kininogen and contains the sequence for bradykinin: its synthesis is regulated at the mRNA level.

Authors:  T Cole; A S Inglis; C M Roxburgh; G J Howlett; G Schreiber
Journal:  FEBS Lett       Date:  1985-03-11       Impact factor: 4.124

2.  Pharmacological properties of T-kinin (isoleucyl-seryl-bradykinin) from rat plasma.

Authors:  H Okamoto; L M Greenbaum
Journal:  Biochem Pharmacol       Date:  1983-09-01       Impact factor: 5.858

3.  Properties of leukokininogen isolated from human neoplastic ascites.

Authors:  S Roffman; L M Greenbaum
Journal:  Biochem Pharmacol       Date:  1979-04-01       Impact factor: 5.858

4.  Isolation and structure of T-kinin.

Authors:  H Okamoto; L M Greenbaum
Journal:  Biochem Biophys Res Commun       Date:  1983-04-29       Impact factor: 3.575

Review 5.  Pharmacology of bradykinin and related kinins.

Authors:  D Regoli; J Barabé
Journal:  Pharmacol Rev       Date:  1980-03       Impact factor: 25.468

6.  Differing utilization of homologous transcription initiation sites of rat K and T kininogen genes under inflammation condition.

Authors:  R Kageyama; N Kitamura; H Ohkubo; S Nakanishi
Journal:  J Biol Chem       Date:  1987-02-15       Impact factor: 5.157

7.  T-kininogen--the major plasma kininogen in rat adjuvant arthritis.

Authors:  A Barlas; H Okamoto; L M Greenbaum
Journal:  Biochem Biophys Res Commun       Date:  1985-05-31       Impact factor: 3.575

8.  Human cystatin, a new protein inhibitor of cysteine proteinases.

Authors:  J Brzin; T Popovic; V Turk; U Borchart; W Machleidt
Journal:  Biochem Biophys Res Commun       Date:  1984-01-13       Impact factor: 3.575

9.  Human Ile-Ser-bradykinin, identical with rat T-kinin, is a major permeability factor in ovarian carcinoma ascites.

Authors:  G Wunderer; I Walter; E Müller; A Henschen
Journal:  Biol Chem Hoppe Seyler       Date:  1986-12

10.  Isolation of a thiol-activated T-kininogenase from the rat submandibular gland.

Authors:  A Barlas; X X Gao; L M Greenbaum
Journal:  FEBS Lett       Date:  1987-06-29       Impact factor: 4.124

View more
  2 in total

1.  Pro-inflammatory properties of the kallikrein-kinin system: potential for new drug therapy.

Authors:  J N Sharma; A P Yusof
Journal:  Inflammopharmacology       Date:  1998       Impact factor: 4.473

2.  Structure-activity studies on bradykinin and related peptides: agonists.

Authors:  N E Rhaleb; G Drapeau; S Dion; D Jukic; N Rouissi; D Regoli
Journal:  Br J Pharmacol       Date:  1990-03       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.